medigraphic.com

2007, Number 5

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2007; 45 (5)

Knowledge about phytopharmaceuticals among physicians affiliated to secondary care hospitals

Romero-Cerecero O, Tortoriello-García J

Language: Spanish
References: 10
Page: 453-458
PDF size: 127.32 Kb.


ABSTRACT

Objective: to analyze the knowledge about phytopharmaceuticals of specialists affiliated to secondary care hospitals in the State of Morelos, Mexico.
Material and methods: the study was conducted through a survey in which 278 medical doctors participated. They were randomly selected from Instituto Mexicano del Seguro Social (IMSS), Sistema de Salud de Morelos (SSM) and private practice facilities. Their knowledge was rated as: “low”, “medium”, and “advanced”. To determine the frequency and distribution of the variables, univariate analysis was done and to ascertain the associations between variables, the χ2 test was used.
Results: 79.1% of physicians had low level of knowledge; 11.1% had medium level and 9.1% had advanced knowledge; the variable “working in the morning shift” was associated with advanced knowledge (p = 0.036).
Conclusions: The low level of knowledge about phytopharmaceuticals should prompt to include this topic within the academic programs of health workers and the continuous medical education activities for practicing physicians.


REFERENCES

  1. Bhattaram VA, Graefe U, Kohlert C, Veit M, Derendorf H. Pharmacokinetics and bioavailability of herbal medicinal products. Phytomedicine 2002;9(3):1-33.

  2. Calixto JB. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz J Med Biol Res 2000;33(2):179-189.

  3. Iten F, Reichling J, Saller R. Adverse effects and interactions of phytotherapeutic drugs. Ther Umsch 2002;59(6):283-291.

  4. Allemann C, Herren D, Badertscher KM. Requeriments for quality of approved plant medicines. Ther Umsch 2002;59(6):267-273.

  5. Organización Mundial de la Salud. Guías para el asesoramiento y la regulación de las medicinas tradicionales. Ginebra, Suiza: OMS; 1992.

  6. García-González M, Cáceres A. Legislación en Iberoamérica sobre fitofármacos y productos naturales. Costa Rica: Universidad de Costa Rica; 2000. p. 327-341.

  7. Ley General de Salud. Reglamento de insumos para la salud. México: Editorial Porrúa; 2000.

  8. Romero-Cerecero O, Reyes-Morales H, Herrera-Arellano A, Lozoya-Legorreta X, Tortoriello J. Aceptación de los fitofármacos por médicos y pacientes en clínicas de atención primaria. Rev Med IMSS 2004;42(2):133-139.

  9. Lozoya X. Los fitofármacos del IMSS. Periodismo de Ciencia y Tecnología; 2001.

  10. Romero-Cerecero O, Reyes-Morales H, Torres Torrija-Barrio I, Herrera-Arellano A, Tortoriello-García J. Conocimiento sobre los fitofármacos en médicos de atención primaria del estado de Morelos. Rev Med IMSS 2005;43(4):281-286.




2020     |     www.medigraphic.com